Close Menu

NEW YORK –  Novacyt said on Monday that it has partnered with German company BioType Diagnostic to manufacture its COVID-19 test. Under the agreement, BioType, based in Dresden, has delivered the first batches of products for final assembly to Primerdesign, Novacyt's UK-based molecular diagnostics division. 

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.